For: | Safe S, Shrestha R, Mohankumar K, Howard M, Hedrick E, Abdelrahim M. Transcription factors specificity protein and nuclear receptor 4A1 in pancreatic cancer. World J Gastroenterol 2021; 27(38): 6387-6398 [PMID: 34720529 DOI: 10.3748/wjg.v27.i38.6387] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i38/6387.htm |
Number | Citing Articles |
1 |
Le Deng, Gaosi Xu, Qipeng Huang. Comprehensive analyses of the microRNA–messenger RNA–transcription factor regulatory network in mouse and human renal fibrosis. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.925097
|
2 |
Lakshmi Vineela Nalla, Piyush Gondaliya, Kiran Kalia, Amit Khairnar. Targeting specificity protein 1 with miR-128-3p overcomes TGF-β1 mediated epithelial-mesenchymal transition in breast cancer: An in vitro study. Molecular Biology Reports 2022; 49(7): 6987 doi: 10.1007/s11033-022-07466-2
|
3 |
Guoying Wang, Xin Ni, Jintian Wang, Ming Dai. METTL3-mediated m6A methylation of PYGB facilitates pancreatic ductal adenocarcinoma progression through the activation of NF-κB signaling. Pathology - Research and Practice 2023; 248: 154645 doi: 10.1016/j.prp.2023.154645
|
4 |
Seyed Hesamoddin Bidooki, María A. Navarro, Susana C. M. Fernandes, Jesus Osada. Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?. Current Issues in Molecular Biology 2024; 46(4): 3134 doi: 10.3390/cimb46040197
|
5 |
Bang-Hua Zhong, Yu-Teng Ma, Jian Sun, Jing-Tong Tang, Ming Dong. Transcription factor FOXF2 promotes the development and progression of pancreatic cancer by targeting MSI2. Oncology Reports 2024; 52(1) doi: 10.3892/or.2024.8752
|
6 |
Fuchen Lou, Mingbao Zhang. RFC2 promotes aerobic glycolysis and progression of colorectal cancer. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02984-0
|
7 |
Jooeun Bae, Shuichi Kitayama, Zach Herbert, Laurence Daheron, Keiji Kurata, Derin B. Keskin, Kenneth Livak, Shuqiang Li, Mubin Tarannum, Rizwan Romee, Mehmet Samur, Nikhil C. Munshi, Shin Kaneko, Jerome Ritz, Kenneth C. Anderson. Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma. Blood 2024; 143(10): 895 doi: 10.1182/blood.2023020528
|